Condition: Solid Tumor · Sponsor: Genentech, Inc.
This is a first-in-human Phase I/II, open-label, multicenter, dose-escalation and expansion study designed to evaluate the safety, pharmacokinetics, and preliminary activity of GDC-7035 as a single agent and in combination with other anti-cancer therapies in participants with advanced or metastatic solid tumors that harbor the KRAS G12D mutation.
This description comes directly from the study's public registry record.
Reference Study ID Number: GO45416 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S.) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| UC San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Sarah Cannon Research Institute at HealthONE | Denver, Colorado, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Florida Cancer Specialist-Lake Mary | Lake Mary, Florida, United States | Completed |
| University of Illinois | Chicago, Illinois, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| START - Midwest - EDOS | Grand Rapids, Michigan, United States | Recruiting |
| Montefiore Einstein Cancer Center | The Bronx, New York, United States | Recruiting |
| Mary Crowley Medical Research Center | Dallas, Pennsylvania, United States | Recruiting |
| Abramson Cancer Center;Univ of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| SCRI Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| O'Quinn Medical Tower at McNair Campus | Houston, Texas, United States | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06619587